Welcome to the first edition of the Life Sciences Consulting Insights.
We bring to you the latest business & technology trends in Life Sciences sector that are setting the course for the challenges & opportunities ahead.
In this issue:
- R&D Transformation: As pharma companies are mitigating investment risks with head-strong inorganic growth, capability-driven collaborations and strategic partnerships along the R&D value chain are likely to remain the primary force for driving innovation among top players.
- Life Sciences Tech Radar: The market outlook for investment in tech companies for the rest of the year is largely positive, on account of rising focus on innovation and commercialization, along with other industry tailwinds, such as favorable changes in regulatory landscape and potentially attractive valuations of start-ups and scale-ups in Life Sciences space.
- Disruption-as-an-Accelerator: As the Life Sciences sub-sectors – Pharma & Biotech, Medical Devices & Diagnostics, and Healthcare – rapidly adopt innovation across the value chain, we take an in-depth look at three key trends that will accelerate and disrupt the Life Sciences and relative landscape.
The Life Sciences Consulting Insights is published quarterly in English and highlights key global trends curated by our KPMG Life Sciences sector and consulting experts.
You can also subscribe to the current and upcoming newsletters to stay ahead with us.
Partner, Consulting, CIO Advisory
KPMG AG Wirtschaftsprüfungsgesellschaft